School of Sports and Health Sciences
Exeter, Devon, EX1 2LU, United Kingdom
NCT Number: NCT03304197
This study will evaluate the effects manipulating ingested fluids can have on hydration status and cycling performance. There will be 4 different conditions.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Exeter, Devon, EX1 2LU, United Kingdom
Being dehydrated can decrease endurance exercise performance. The investigators wish to test which of three drinks is most effective at re-hydrating cyclists and if this affects performance. Subjects will undertake 4 tests: once dehydrated, once hydrated with water, once hydrated with a sports-specific drink, and once with an altered sports drink. Blood samples will be taken and expired gasses will be sampled at various time points throughout the tests for later analysis. A small amount of labelled water will be consumed with each drink, a technique which will allow us to quantify the absorption of each of the drinks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
N/A: see arm description
N/A: see arm description
N/A: see arm description
N/A: see arm description
Time frame: To begin 10 minutes after the completion of the 90 minute steady-state cycle
Absorption of drinks through the gut will be measured using 2 boluses of deuterated water. This will be consumed alongside 2 of the drinks, and blood samples will be used to quantify enrichment. Total body water calculations are required to provide corrections in equations related to D2O. H218O will be consumed in order to quantify total body water: this will be provided in a single bolus before each trial.
Time frame: Throughout the 90 minute steady-state cycle & the 15 minute time trial.
Subjects will perform a cycle ergometer protocol that has been shown to be reproducible in athletes. Subjects will complete the time trial on a Lode Excalibur cycling ergometer. Software linked to this software will record work done and power output.
Time frame: Throughout the 90 minute steady-state cycle
Substrate utilisation will be calculated from data collected through a metabolic cart and its software. It will be measured during the 90-minute steady-state cycle for 4 periods of 3 minutes. Carbohydrate and lipid oxidation rates will be calculated using equations by Jeukendrup & Wallis (2005).
Time frame: Throughout the 90 minute steady-state cycle and time-trial
A cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma glucose, plasma lactate, haemoglobin content, haematocrit and plasma volume. Remaining whole blood will be centrifuged immediately and its plasma split into aliquots and stored in a -20°C freezer. At the end of the trial, plasma samples will be moved to a -80°C freezer for later analysis for sodium, glycerol, and NEFA.
Time frame: Throughout the 90 minute steady-state cycle and time-trial
Heart rate will be measured throughout with the use of a heart rate monitor.
Time frame: Throughout the 90 minute steady-state cycle and time-trial
RPE will be measured using the Borg Scale.
Time frame: Throughout the 90 minute steady-state cycle and time-trial
Core temperature will be measured throughout with the use of an ingestible core-body temperature pill (HQ Inc, FL, USA).
University of Exeter
Other
How Does Altering the Composition of Ingested Fluids Affect Hydration Status Whilst Cycling?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details